TAK logo

TAK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported8.31%
TAK TTM EBITDA YoY % (-12.32% → 8.31%)
High-resolution chart · PNG

TAK ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
8.3063%
17.5235%
4.997%
-18.8954%
5.3769%
2.919%
34.853%
27.4105%
-6.7907%
-8.8675%
-15.9211%
2.0105%
20.5258%
13.2268%
0.9468%
-8.951%
-8.476%
9.4167%
35.2265%
49.5373%
41.3414%
55.5945%
27.2007%
38.7396%
62.6455%
38.8633%
90.0326%
47.5847%
40.6688%
1.7001%
-24.4968%
-11.3359%
-19.0722%
23.0914%
18.1168%
7.3001%
-2.1563%
9.4995%
496.4487%
222.1999%
260.8689%
151.3223%
-85.8197%
-71.2971%
-73.1373%
-69.3804%
27.0504%
35.1734%
46.2559%
53.6111%
489.1234%
901.7838%
138.9486%
3.4437%
-124.6254%
-92.2911%
-72.6725%
-43.9204%
-19.6248%
-14.7193%
-6.4392%
-9.6935%
-12.5555%
-17.7439%
-12.3228%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.